0001437749-24-006519.txt : 20240304
0001437749-24-006519.hdr.sgml : 20240304
20240304213818
ACCESSION NUMBER: 0001437749-24-006519
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pellegrino Joseph P JR
CENTRAL INDEX KEY: 0001365733
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 24718048
MAIL ADDRESS:
STREET 1: 68 BEACON STREET
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-02-29
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365733
Pellegrino Joseph P JR
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
1
Chief Financial Officer
0
Common Stock
2024-02-29
4
M
0
3461
31.30
A
12996
D
Common Stock
2024-02-29
4
M
0
8733
23.56
A
21729
D
Common Stock
2024-02-29
4
M
0
5883
35.48
A
27612
D
Common Stock
2024-02-29
4
M
0
5346
37.29
A
32958
D
Common Stock
2024-02-29
4
M
0
7031
48.60
A
39989
D
Common Stock
2024-02-29
4
M
0
3430
47.19
A
43419
D
Common Stock
2024-02-29
4
S
0
1979
68.56
D
41440
D
Common Stock
2024-02-29
4
S
0
28461
69.724
D
12979
D
Common Stock
2024-02-29
4
S
0
6250
70.27
D
6729
D
Common Stock
2024-02-29
4
S
0
277
71.19
D
6452
D
Common Stock
2024-02-29
4
M
0
2
0
D
6450
D
Common Stock
2024-02-29
4
A
0
2649
0
A
9099
D
Common Stock
2024-02-29
4
M
0
6
0
A
9105
D
Common Stock
2024-02-29
4
F
0
296
70
D
8809
D
Stock Option (Right to Buy)
31.30
2024-02-29
4
M
0
3461
0
D
2017-12-22
2024-12-22
Common Stock
3461
0
D
Stock Option (Right to Buy)
23.56
2024-02-29
4
M
0
8733
0
D
2018-12-19
2025-12-19
Common Stock
8733
0
D
Stock Option (Right to Buy)
35.48
2024-02-29
4
M
0
5883
0
D
2019-12-20
2026-12-20
Common Stock
5883
2941
D
Stock Option (Right to Buy)
37.29
2024-02-29
4
M
0
5346
0
D
2020-12-02
2027-12-02
Common Stock
5346
5345
D
Stock Option (Right to Buy)
48.60
2024-02-29
4
M
0
7031
0
D
2021-12-11
2028-12-11
Common Stock
7031
7030
D
Stock Option (Right to Buy)
47.19
2024-02-29
4
M
0
3430
0
D
2022-12-12
2029-12-12
Common Stock
3430
10291
D
Dividend Equivalent Rights
2024-02-29
4
M
0
6.683
0
D
Common Stock
6.683
20.0592
D
Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $68.05 to $69.04. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $69.05 to $70.045. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $70.05 to $70.62. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
Represents shares from the release of fractional dividend equivalent rights returned to company.
These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years.
Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.
Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
This option is fully vested and exercisable.
This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.
These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
/s/ David C. Hissong
2024-03-04